ArticleDigestive diseases and sciences2015

Low SVR rates in clinical practice for treating genotype 1 chronic hepatitis C with protease inhibitors boceprevir and telaprevir.

Perry H Dubin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.